Take Part

Find out more about what is involved in the ENERGISE-BD Trial and how you can register your interest in participating.

Watch our video to learn more about participating in our trial or read below.

What is ENERGISE-BD?

This study will compare the impact of using nutritional ketosis (following a diet which is high in fat and very low in carbohydrates, so your body will switch to burning fat for energy) or the NHS EatWell guide (eating a variety of foods to achieve a healthy, balanced diet) for 12 weeks on depressive symptoms in people with bipolar disorder.

Each participant will be randomly allocated to one of the two diets, giving them an equal chance of being assigned to either group. They will continue their usual treatment for bipolar disorder at the same time. We will study aspects of mental and physical health before, during and after the diets to see if either is an effective treatment for bipolar depression.

Who can take part?

To be eligible to take part in the study, you need to be an adult (over 18 years old) with a diagnosis of bipolar disorder and be experiencing significant depressive symptoms. 

You will not be able to take part if:

  • You have certain conditions, such as liver failure or type 1 diabetes
  • You are currently experiencing abnormally high mood (mania) 
  • You don’t have access to a smartphone, as you will check the levels of ketones and glucose in your blood each day at home using finger-prick blood tests and a KetoMojo device, and then record these in a smartphone app.
  • You may also not be able to take part if you have previously used a diet to promote nutritional ketosis (within the last 2 months) or are using certain weight-loss medications, as this could affect the accuracy of the study measurements.

The team will check your eligibility to take part in the study during the initial appointment. If you would like to ask any questions about this, please contact us at ENERGISE-BD@ed.ac.uk.

What will I be asked to do?

We will ask you to be in the study for 24 weeks and to follow a diet plan for 12 weeks. The study involves:

  • A screening assessment (by phone or video call)
  • A baseline assessment (in clinic) involving questionnaires, body measurements, blood samples, brain scans (for some Edinburgh participants) and the allocation of your diet. 
  • Following your allocated diet for 12 weeks including weekly contact with a dietitian, and taking daily ketone measurements.
  • A follow up scan (in clinic) at week six if you were scanned at baseline
  • A follow up appointment (in clinic) at week 12 involving a reassessment of baseline measures, and a final brain scan (if completed at baseline)
  • A follow up appointment (by phone or video call) at week 24 involving questionnaires.

We are also carrying out a process evaluation as part of this trial. The aim is to understand how the trial is delivered, how patients and healthcare professionals experience it, and whether any improvements can be made for future studies. If you choose to take part, you may be invited to a short interview (in person, online, or by phone) at different points during the trial. If you agree to share your contact details with the process evaluation team, they will provide more information about what taking part involves. 

Participant Information Sheet and Consent Form

Before registering your interest, please download our participant information sheet and consent information for full information about participating in the trial. Please note that registrations are currently open for Edinburgh and the central belt of Scotland, with the Birmingham site opening early 2027.